As of November 7, 2026, one holder's latest Schedule 13D or 13G filing report owning 5% or more of Maxcyte, Inc. The largest reported stake is Capricorn Fund Managers Ltd's, at 7.7%. 14 filings are on record since October 24, 2025 (Schedule 13G, February 5, 2026).
Sell to companies like Maxcyte, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Liontrust Investment Partners LLP · Sole voting: 5,081,403 · Shared voting: 0 · Sole dispositive: 5,081,403 · Shared dispositive: 0 · SCHEDULE 13D, 2026-11-02
- · Holder: Liontrust Investment Partners LLP · Percent: 5% · SCHEDULE 13D
- · Reporting person: River Global Investors Llp · Sole voting: 834,100 · Shared voting: 0 · Sole dispositive: 834,100 · Shared dispositive: 0 · SCHEDULE 13D, 2026-08-04
- · Reporting person: BlackRock, Inc. · Sole voting: 1,402,591 · Shared voting: 0 · Sole dispositive: 1,402,591 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-07-29
- · Holder: River Global Investors Llp · Percent: 6.1% · SCHEDULE 13D
Maxcyte, Inc. has 14 Schedule 13D or 13G filings on record since 2025-10-24. 1 holder's latest filing reports 5% or more of equity. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Capricorn Fund Managers Ltd | 7.7% | 8,200,000 | SCHEDULE 13G, 2026-02-05 | 2026-01-30 |
| Liontrust Investment Partners LLP | 4.9% | 5,081,403 | SCHEDULE 13D, 2026-11-02 | 2026-10-30 |
| Cadian Capital Management, LP | 3.5% | 3,683,052 | SCHEDULE 13G/A, 2026-02-17 | 2025-12-31 |
| BlackRock, Inc. | 1.3% | 1,402,591 | SCHEDULE 13G/A, 2026-07-29 | 2026-06-30 |
| River Global Investors Llp | 0.8% | 834,100 | SCHEDULE 13D, 2026-08-04 | 2026-07-31 |
| Mirabella Financial Services LLP | 0% | 0 | SCHEDULE 13G/A, 2026-04-10 | 2026-03-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
Holding shares or following this stake? See who's behind Maxcyte, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Maxcyte, Inc. and the records around it.
Maxcyte, Inc. elsewhere on the record
Companies that share a holder
- Capricorn Fund Managers Ltd also filed stake reports on 3 other companies: Blend Labs, Inc. (Oct 2026), KINGSWAY Corp (Jul 2026), Beauty Health Co (Jul 2026)
- Mirabella Financial Services LLP also filed stake reports on 3 other companies: Kingsway Financial Services Inc (Apr 2026), Beauty Health Company (Feb 2026)
- Cadian Capital Management, LP also filed stake reports on 7 other companies: Cryoport, Inc. (Aug 2026), Flywire Corp. (Aug 2026), SI-BONE, Inc. (Aug 2026)
Watch Maxcyte, Inc.
Get an email when Maxcyte, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Maxcyte, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Maxcyte, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Maxcyte, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
14 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Liontrust Investment Partners LLP | 5,081,403 | 0 | 5,081,403 | 0 | SCHEDULE 13D, 2026-11-02 |
| BlackRock, Inc. | 1,402,591 | 0 | 1,402,591 | 0 | SCHEDULE 13G/A, 2026-07-29 |
| River Global Investors Llp | 834,100 | 0 | 834,100 | 0 | SCHEDULE 13D, 2026-08-04 |
The latest filing identifies Maxcyte, Inc. by CUSIP 57777K106 and gives its principal executive office as 9713 KEY WEST AVENUE, SUITE 400, ROCKVILLE, MD 20850 (SCHEDULE 13D, 2026-11-02).
Purpose of Transaction (Item 4)
River Global Investors Llp
(b) An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the issuer or any of its subsidiaries. As per the Announcement on 24 June 2026 (RNS Number: 4421J), the FCA has approved the change in control and proposed acquisition of River Global Holdings Limited. Subsequently, as of close of business on 31 July 2026, Liontrust Investment Partners (LIP) LLP assumed responsibility for the River Global Investors (RGI) LLP ICVC and ICAV funds. The relevant voting rights (approx 4.3%) attached to those holdings have therefore transferred from RGI LLP to LIP LLP. The remaining voting rights (approx 0.8%) continue to be held by RGI LLP and will be transferred at a later stage.Item 4 of the SCHEDULE 13D filed 2026-08-04
Liontrust Investment Partners LLP
(a) The acquisition by any person of additional securities of the issuer, or the disposition of securities of the issuerItem 4 of the SCHEDULE 13D filed 2026-11-02
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-10-24 | River Global Investors Llp | 5.2% | SCHEDULE 13D |
| 2025-11-03 | Mirabella Financial Services LLP | 6.2% | SCHEDULE 13G |
| 2025-11-04 | Mirabella Financial Services LLP | 7.69% | SCHEDULE 13G/A |
| 2025-11-14 | Cadian Capital Management, LP | 7.7% | SCHEDULE 13G/A |
| 2026-01-21 | BlackRock, Inc. | 6.6% | SCHEDULE 13G/A |
| 2026-02-05 | Capricorn Fund Managers Ltd | 7.7% | SCHEDULE 13G |
| 2026-02-17 | Cadian Capital Management, LP | 3.5% | SCHEDULE 13G/A |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-10 | Mirabella Financial Services LLP | 0% | SCHEDULE 13G/A |
| 2026-05-14 | River Global Investors Llp | 6.1% | SCHEDULE 13D |
| 2026-07-29 | BlackRock, Inc. | 1.3% | SCHEDULE 13G/A |
| 2026-08-04 | River Global Investors Llp | 0.8% | SCHEDULE 13D |
| 2026-10-15 | Liontrust Investment Partners LLP | 5% | SCHEDULE 13D |
| 2026-11-02 | Liontrust Investment Partners LLP | 4.9% | SCHEDULE 13D |
Questions about who owns Maxcyte, Inc.
Who owns Maxcyte, Inc.?
On this page, one holder's latest ownership filing reports 5% or more of Maxcyte, Inc.: Capricorn Fund Managers Ltd (7.7%, Schedule 13G, filed 2026-02-05).
When did Capricorn Fund Managers Ltd buy into Maxcyte, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Capricorn Fund Managers Ltd on this page is the Schedule 13G, filed 2026-02-05, reporting 7.7%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 14 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Maxcyte, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.